
Psychedelic Therapy 2026: MDMA, Psilocybin, Phase III Trials, FDA and Status in Poland
MDMA in PTSD and psilocybin in treatment-resistant depression: what phase III studies have shown, why the FDA refused registration, and what the legal status is in Poland.














